EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

The International Liver Congress 2017

 

19-23 April 2017 Amsterdam
Close
N. Poster
Poster title
Applicant name
Status
  THU-003 Von Willebrand Factor as a predictor of short-term morbidity and mortality in comparison with conventional scoring systems Aditya Vivekanand Kulkarni Received Received
  THU-004 Early initiation of carvedilol is safe and cost effective in cirrhotic patients presenting with upper GI bleed following endoscopic therapy: results of a prospective randomized trial Adnan Salim Received Received
  THU-005 Platelet count, spleen length and platelet count/spleen length ratio for the diagnosis of oesophageal varices in patients with hepatic cirrhosis. A systematic review and meta-analysis Agostino Colli Received Received
  THU-007 A chronic disease management model for chronic liver failure is cost-effective; cost-effectiveness analysis Alan J Wigg Received Received
  THU-008 Spontaneous bacterial empyem revisited Alberto Amador Received Received
  SAT-008 Rifaximin for the prevention and treatment of hepatic encephalopathy: a systematic review with meta-analyses of randomised controlled trials Nina Kimer Received Received
  THU-009 Outcome of liver transplant recipients after the first episode of bacterial infection Alberto Ferrarese Received Received
  FRI-012 time in HE in cirrhotic patients with an acute episode (=grade 2) determines short and long-term survival Meritxell Ventura Cots Received Received
  THU-013 High serum human beta-defensin-1 is associated with increased short-term mortality in patients with decompensated cirrhosis Alexandra Alexopoulou Received Received
  THU-014 Prospective study of gastrointestinal tract colonization with multidrug resistant bacteria and potential association with infection development and survival in patients with decompensated cirrhosis Alexandra Alexopoulou Received Received
  THU-015 Single center validation of scores for prediction of mortality in patients with acute-on-chronic liver failure or acute decompensation of cirrhosis without acute-on-chronic liver failure Alexandra Alexopoulou Received Received
  SAT-015 PALBI - the platelet-albumin-bilirubin score – a better predictor of outcome of acute variceal bleeding Omar Elshaarawy Received Received
  THU-016 Uncontrolled glycaemia increases the risk of developing spontaneous bacterial peritonitis in patients with cirrhosis Fatima Higuera-de La Tijera Received Received
  THU-017 Metabolic risk factors increase the risk of hepatocellular carcinoma in patients with hepatitis C cirrhosis Alina Kutsenko Received Received
  SAT-018 The addition of splenic and superior mesenteric vein respiratory excursions to Baveno VI criteria can save more endoscopies without compromising its diagnostic accuracy Paolo Del Poggio Received Received
  THU-019 Mortality of variceal bleeding admitted to the intensive care unit: an Australasian study Ammar Majeed Received Received
  THU-022 The diagnostic and prognostic value of serum endocan in patients with cirrhotic cardiomyopathy Andrei Mihai Voiosu Received Received
  FRI-024 An Innovative app focused on patients and caregivers significantly decreases avoidable and HE-related readmissions in cirrhotic patients Jasmohan Singh Bajaj Received Received
  FRI-025 Albumin use and acute kidney injury in a large real-world analysis of cirrhotic inpatients Jasmohan S Singh Bajaj Received Received
  THU-026 The natural history of covert hepatic encephalopathy in cirrhotic patients in a tertiary care hospital Anjiang Wang Received Received
  SAT-027 Modification of deranged systemic hemodynamic parameters and impaired intestinal permeability with slow infusion of furosemide and albumin with or without terlipressin in patients with refractory ascites Prabhat Narain Sharma Received Received
  THU-027 Long-term prognosis following acute-on-chronic liver failure Eileen L. Yoon Received Received
  THU-028 Clinical significance of urinary neutrophil gelatinase-associated lipocalin measurement in differentiating various etiologies of acute kidney injury in cirrhotic patients Eileen L. Yoon Received Received
  THU-029 Bacterial deoxyribonucleic is frequent in blood samples of patients with compensated cirrhosis and obesity and is associated with lack of decrease of portal pressure after an intensive lifestyle intervention Annalisa Berzigotti Received Received
  SAT-030 Carvedilol is associated with improved survival in patients with decompensated cirrhosis Rohit Sinha Received Received
  FRI-031 Performance of upper gastrointestinal bleeding risk assessment scores in variceal bleeding: a prospective international multicenter study Yung Ka Chin Received Received
  FRI-034 Patients with alcoholic-related cirrhosis have high burden of coronary arteriosclerosis compared to non-alcohol-related cirrhosis Karen Vagner Danielsen Received Received
  FRI-036 Medication beliefs predict low medication adherence in people with decompensated cirrhosis Kelly Lee Hayward Received Received
  FRI-043 Cellulitis is a common precipitant of acute kidney injury and mortality in patients with cirrhosis Luis Téllez Received Received
  FRI-045 Non-invasive measures to predict the presence of oesophageal varices in real life practice Mafalda Sousa Received Received
  FRI-046 GR3027 reverses neurosteroid-induced, GABAA receptor-mediated inhibition of brain function: A human challenge study Maja Johansson Received Received
  FRI-047 Changes in the model for end-stage liver disease (MELD) scores on day 7 predict mortality in acute on chronic liver disease: the delta-MELD project Majd B Protty Received Received
  SAT-047 Efficacy of nutritional therapy on quality of life in liver cirrhosis with minimal hepatic encephalopathy- randomized controlled trial Sudhir Maharshi Received Received
  FRI-050 The emerging role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses Marcus Maximilian Mücke Received Received
  FRI-051 Abnormalities in skin temperature and its 24-hour rhythm in patients with cirrhosis: sleep-wake and general clinical implications Maria Garrido Received Received
  THU-055 Minimal hepatic encephalopathy is associated with increased capacity to eliminate superoxide and peroxynitrite in lymphocytes Carmina Montoliu Received Received
  FRI-059 Beneficial effects of octrotide on intrahepatic angiogenesis via somatostatin receptor 2 in portal hypertensive and cirrhotic rats Jinhang Gao Received Received
  SAT-060 Treatment with anti-TNFa reduces neuroinflammation and restores neurotransmission, learning and motor coordination in rats with hepatic encephalopathy Vicente Felipo Received Received
  THU-062 Extracellular vesicles induce renal tubular cells apoptosis, oxidative stress and functional abnormalities in patients with an acute decompensation of cirrhosis Alessandra Brocca Received Received
  FRI-063 Inhibition of macrophage infiltrations by thalidomide improves muscle wasting of cirrhotic rats Han-Chieh Lin Received Received
  SAT-068 Elevated levels of circulating osteopontin in patients with cholangiocarcinoma predict poor survival after tumor resection Sven H. Loosen Received Received
  THU-069 The systemic inflammatory response is a prognostic marker in human immunodeficiency virus-infected patients with hepatocellular carcinoma David James Pinato Received Received
  SAT-074 Validation of novel eligibility criteria by integrating ALBI grade and progression pattern for sorafenib-failed hepatocellular carcinoma Pei-Chang Lee Received Received
  FRI-078 Temporary suspension of sorafenib by adverse effects is associated with longer survival in patients with hepatocellular carcinoma Maria Varela Received Received
  FRI-079 Functional health literacy can affect patient perception for the need for liver imaging for HCC screening Jasmohan Singh Bajaj Received Received
  SAT-082 The diagnostic and prognostic values of serum PIVKA-II in Thai patients with hepatitis B-related hepatocellular carcinoma Pisit Tangkijvanich Received Received
  SAT-083 Adjuvant Huaier granule for hepatocellular carcinoma after curative resection: A phase IV, multicenter, randomized, and parallel-group controlled clinical trial Qian Chen Received Received
  THU-085 Risk of hepatocellular carcinoma development in patients with cirrhosis of viral etiology assessed by protein induced by vitamin k absence or antagonist II Gian Paolo Caviglia Received Received
  SAT-085 Significantly lower rates of cirrhosis and worse long-term survival in cryptogenic hepatocellular carcinoma compared to viral etiologies: results of a multi-center international cohort Tomi Jun Received Received
  THU-086 The role of spleen stiffness measurement as predictor of hepatocellular carcinoma recurrence after curative resection in cirrhotic patients Giovanni Marasco Received Received
  SAT-087 Significance of serum exosomal miR-122 and miR-21 as a predictive biomarker in hepatocellular carcinoma patients who underwent transarterial chemoembolization Tomoyuki Suehiro Received Received
  SAT-088 Validation of a simple scoring system to predict sorafenib effectiveness in patients with hepatocellular carcinoma Rocco Granata Received Received
  SAT-089 A combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin Torsten Voigtländer Received Received
  FRI-089 Safety and efficacy of chemosaturation in patients with primary and secondary liver tumours: a single-centre experience after 54 treatments Martha M Kirstein Received Received
  THU-089 The effect of antiviral treatment on hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma Gab Jin Cheon Received Received
  SAT-090 Extent of portal invasion in patients with hepatocellular carcinoma: the more, the worse? Roman Kloeckner Received Received
  FRI-091 Novel circulating cell free DNA methylation alterations as a biomarker for the detection of hepatocellular carcinoma Ju Dong Yang Received Received
  THU-092 Alpha-fetoprotein levels before and after sustained virological response with direct- acting antivirals in patients with liver cirrhosis due to hepatitis C virus Carmen Alvarez-Navascues Received Received
  FRI-092 Validation of the ALBI grade as a substitute for the Child-Pugh class in the BCLC classification of hepatocellular carcinoma and of the additional value provided by the Neutrophil-to-Lymphocyte Ratio Matteo Colombo Received Received
  THU-097 Hepatocellular carcinoma and rheumatoid arthritis: a 10-year population-based propensity-score matched cohort study in Taiwan Ching-Sheng Hsu Received Received
  SAT-099 Utility of serum alpha-fetoprotein measurement with a cutoff of 20ng/mL in addition to ultrasound surveillance for hepatocellular carcinoma in patients with chronic hepatitis B - a regression discontinuity analysis Yan-Zheng Daniel Lim Received Received
  SAT-103 Analysis of postprogression survival of patients with advanced hepatocellular carcinoma treated with sorafenib Yoshiyuki Wada Received Received
  THU-107 Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational study David James Pinato Received Received
  THU-109 Intra-tumour heterogeneity in the regulation of immune-tolerogenic pathways in primary and metastatic hepatocellular carcinoma David James Pinato Received Received
  FRI-113 Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumor classification Julien Calderaro Received Received
  FRI-115 Genetic and epigenetic bases of the relationship between reduced OCT1 expression and poor response to sorafenib in hepatocellular carcinoma and cholangiocarcinoma Jose J.G. Marin Received Received
  THU-117 Tumour suppressor SH2D4A is involved in endosomal trafficking of STAT3 in hepatocellular carcinoma cells Carolin Ploeger Received Received
  SAT-120 Exome sequencing identifies a mutation associated with hepatocellular carcinoma development in hepatitis C virus infected individuals Rodrigo Feliciano Carmo Received Received
  THU-122 RIPK1 suppresses a TRAF2-dependent pathway to liver cancer Tom Luedde Received Received
  SAT-131 AKT inhibitor ARQ 092 and sorafenib additively inhibit progression of hepatocellular carcinoma and improve immune system in cirrhotic rat model Zuzana Macek Jilkova Received Received
  FRI-131 Interferon-free antiviral therapy does not increase the risk of developing short term hepatocellular carcinoma in patients with cirrhosis infected with hepatitis C virus Andrea Nuñez Received Received
  SAT-133 Incidence and mortality of viral hepatitis in China Mingyuan Zhang Received Received
  FRI-137 Association between mutations on the basal core promoter region and hepatocellular carcinoma in Vietnamese chronic hepatitis B patients Cam Huong Thi Nguyen Received Received
  THU-138 Impact of chronic liver disease on the survival of patients hospitalized with acute hepatitis A infection: nationwide hospital admission data from Thailand Kittiyod Poovorawan Received Received
  THU-139 A nationwide seroprevalence of hepatitis a in Republic of Korea from 2005 to 2014, before and after peak outbreak in 2009 Sook-Hyang Jeong Received Received
  FRI-139 Phenotypic and genotypic shifts of hepatitis B virus in treatment naïve patients following extensive use of antivirals in a chronic hepatitis B endemic area Chau-Ting Yeh Received Received
  FRI-140 Identificaiton of an hot integration area for hepatitis B viral genome in the tenth intron of DEP Domain-Containing 5 gene in hepatoma patients with unfavorable postoperative prognosis Chau-Ting Yeh Received Received
  SAT-140 Poor adherence to hepatitis B screening protocols prior to rituximab; a multicentre South Australian study Alan Wigg Received Received
  SAT-141 A territory-wide study on the seroprevalence of hepatitis B and C virus in the general population in Hong Kong, China Sze Hang Kevin Liu Received Received
  FRI-141 Increased natural killer cell function after structured interruption of long-term nucleos(t)ide analogue therapy is associated with active hepatitis Christine Lea Zimmer Received Received
  SAT-143 Identifying true inactive HBV carriers using fibrosis-4 index Tai-Chung Tseng Received Received
  THU-143 Nucleos(t)ide analogue decreased liver stiffness of e-antigen negative chronic hepatitis B (CHB) patients over a 10-year interval Lung-Yi Mak Received Received
  FRI-143 Characterization and evaluation of hepatic fibrosis degree in patients with chronic hepatitis B virus infection with normal transaminases Cristina San Juan Received Received
  SAT-148 Hepatitis E virus activates signal transducer and activator of transcription 3 to facilitate viral replication Wenshi Wang Received Received
  THU-150 Liver histologic spectrum in hepatitis B virus patients co-infected with the human immunodeficiency virus Mauricio Lisker-Melman Received Received
  SAT-154 Characterization of hepatitis delta infection in Israel: prevalence and genotypes Orna Mor Received Received
  FRI-155 An algorythm including quantitave HBsAg and HBcrAg is useful for discrimation between hepatitis B virus inactive carriers and patients with active chronic hepatitis B HBeAg negative Mar Riveiro Barciela Received Received
  FRI-159 Baseline serum WFA+-M2BP level is a strong predictor of response to pegylated interferon-a in HBeAg-positive chronic hepatitis B patients Mingyu Zhu Received Received
  SAT-159 Kinetics of serum HBsAg and HBcrAg in predicting response to pegylated interferon-based therapy in patients with HBeAg-negative chronic hepatitis B Pisit Tangkijvanich Received Received
  FRI-160 Next generation sequencing identifies baseline HBV mutants associated with treatment response to pegylated interferon in patients with HBeAg-positive chronic hepatitis B Natthaya Chuaypen Received Received
  FRI-167 Identification of hepatitis B X protein regions responsible for the regulation of HBV transcription via histone modification Danny Ka Ho Wong Received Received
  FRI-168 Proteomic profiling of plasma proteins associated with spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B Fen Liu Received Received
  THU-169 Absolute quantification of intrahepatic hepatitis B virus covalently-closed-circular DNA by droplet digital PCR technology Gian Paolo Caviglia Received Received
  FRI-173 Relationship between HBsAg, HBV DNA, covalently closed circular DNA and fibrosis stage in chronic HBV (HBeAg-negative) patients Konstantin Kozlov Received Received
  THU-176 A phase 1 study to evaluate safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC-521 in a healthy volunteer population James Hamilton Received Received
  FRI-179 Integrated healthcare system implementation of one time hepatitis C virus testing for patients born between 1945 and 1965 with linkage to care James M Levin Received Received
  FRI-182 Linkage to care of HBsAg and anti-HCV positive patients after a systematic screening approach in the German primary care setting Johannes Wiegand Received Received
  THU-182 Declining prevalence and increasing awareness of hepatitis C virus infection in Italy: A population-based survey Antonio Massimo Ippolito Received Received
  SAT-183 Hepatic expression of oncogenes Bmi1 and Dkk1 can be induced by treatment with Hepatitis B virus particles or Lipopolysaccharide in vitro and is up-regulated in liver biopsies of patients with chronic HBV infection Ruth Broering Received Received
  SAT-184 Insulin enhances HBV replication and interferes with antiviral activity of IFN-a Sandra Marie-Ange Phillips Received Received
  SAT-187 Hepatitis B virus production is enhanced through early autophagic flux but degraded through autophagosome-lysosome fusion Yong Lin Received Received
  FRI-188 IL6-174GG genotype is associated with diabetes mellitus type 2 in patients with chronic hepatitis C Luciana Diniz Diniz Silva Received Received
  FRI-189 Muscle mass is a protector factor against low bone mineral density in hepatitis C Luciana Diniz Silva Received Received
  THU-189 An audit of hepatitis C screening and referral patterns to a specialist hepatology service in a secondary care facility in the UK Anthony Pratt Received Received
  FRI-190 Long-term fibrosis improvement after sustained virologic response in patients with chronic hepatitis C and advanced fibrosis or cirrhosis - pre-treatment cirrhosis, older age and high body mass index increases the risk for persisting fibrosis Magnus Hedenstierna Received Received
  SAT-192 Prevalence of thyroid dysfunction among 21672 Egyptian patients with chronic HCV genotype IV Zeinab Abdellatif Received Received
  SAT-194 Low rates of hepatitis C virus (HCV) testing and HCV awareness among individuals at high risk for chronic HCV infection among an underserved safety-net population Robert Wong Received Received
  SAT-196 Validation of the role of FIB-4 and APRI in the assessment of hepatic fibrosis and prediction of risky varices in Egyptian patients with chronic hepatitis C (genotype 4) Saeed M. El-Nahaas Received Received
  THU-196 Injecting heroin - how long until hepatitis C infection obtained? Brian Stephens Received Received
  THU-201 Diversity of the association of serumlevelsand genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C Chung-Feng Huang Received Received
  THU-204 Understanding factors associated with hepatitis c spontaneous viral clearance: a meta-analysis Dewi Nur Aisyah Received Received
  FRI-206 A novel single daily fixed dose combination of sofosbuvir 400 mg + ribavirin1000 mg + egcg 400 mg is superior to the standard of care as an anti-viral and safer causing less hemolysis in patients with chronic hepatitis C Gamal Shiha Received Received
  SAT-209 Drop of FGF19 levels in patients with HCC development following DAA therapy for chronic hepatitis C Vanessa Stadlbauer Received Received
  FRI-209 Platelets represent an independent predictor of sustained virological response (SVR) in patients with advanced chronic hepatitis C (CHC) treated with current direct acting antiviral(s) (DAA). HERACLIS: Hellenic multicenter real-life cohort study George Papatheodoridis Received Received
  THU-210 Factors that influence the improvement of serum albumin during interferon-free sofosbuvir/ledipasvir therapy for Japanese patients with chronic hepatitis C virus infection Akira Kawano Received Received
  THU-212 Markedly improvement of glycaemic control in diabetic patients with chronic hepatitis C achieving sustained virologic response after direct acting antiviral therapy: results of a prospective controlled study Alessia Ciancio Received Received
  FRI-218 Sofosbuvir-based therapy in patients with chronic hepatitis C virus infection and malignancies – a prospective observational study of 136 patients Harrys Antonio Torres Received Received
  FRI-224 Ribavirin free versus Ribavirin containing therapy with all second generation direct acting antivirals for the treatment of hepatitis C virus genotype 1 infection; a pooled analysis of 4501 patients Hussien Ahmed Received Received
  THU-227 Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study Antonio Massimo Ippolito Received Received
  THU-228 High sustained virological response rates in hepatitis C genotypes 1a and 4 patients treated with elbasvir and grazoprevir and basal viremia >800.000 UI/mL Antonio Olveira Received Received
  THU-235 Direct acting antivirals improve neutrophil phagocytic capacity in chronic hepatitis C Bettina Leber Received Received
  SAT-235 Plasma miR-122 levels in chronic hepatitis C patients achieving sustained virological response following DAA treatment with and without previous anti-miR-122 (RG-101) dosing Meike H. van der Ree Received Received
  SAT-241 Outcomes of daclatasvir + sofosbuvir + riba in HEP C G3 patients who relapsed with SOF + RIBA combination therapy Muzaffar Lateef Gill Received Received
  SAT-242 Comparison of vibration-controlled transient elastography (VCTE) with aspartate aminotransferase-to-platelet ratio Index (APRI) and platelet count for Identification of esophageal varices in patients with cirrhosis Muzaffar Lateef Gill Received Received
  SAT-243 Prevalence and risk factors of hepatitis B virus reactivation in interferon-free direct-acting antiviral therapies for hepatitis C Naoki Kawagishi Received Received
  FRI-244 Fibrosis regression in chronic hepatitis C patients after treatment with direct-acting antiviral agents is more effective than before – comparison of different noninvasive methods Joana Rita Oliveira Alves Rita Carvalho Received Received
  FRI-245 Total cholesterol and low-density lipoprotein increases after treatment with direct-acting antiviral agents – Implications in the future? Joana Rita Oliveira Alves Santos Carvalho Received Received
  FRI-249 Efficacy and safety of Simeprevir-containing hepatitis C therapy in patients on opiate substitution therapy John Dillon Received Received
  SAT-252 Changes in the lipid profile in hepatitis C virus infected patients treated with direct-acting antivirals Pedro Linares Received Received
  THU-253 Effects of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection on serotonin metabolism, depression scores and fatigue Daphne Hahn Received Received
  SAT-257 Improved virological outcomes and excellent safety profile in genotype 3 HCV-infected cirrhotic patients after an extended 24-weeks course of daclatasvir, sofosbuvir + ribavirin: insights from a real-life multicenter study Raffaella Lionetti Received Received
  THU-259 Retreatment of hepatitis C virus daa failures in real life: Easy and difficult to cure patients Denis Ouzan Received Received
  SAT-261 Real world experience: Treating Hepatitis C in Alice Springs, Australia 2007-16 Robert Gordon Batey Received Received
  THU-262 Prospective study of autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct acting antivirals Doroteo Acero Fernández Received Received
  SAT-269 Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation Sarah Shalaby Received Received
  FRI-270 Antiviral therapy in patients with chronic hepatitis C related hepatocellular carcinoma responding to palliative treatment Kwan Sik Lee Received Received
  THU-270 Management of drug-interactions with DAAs in Dutch human immunodeficiency virus/hepatitis C virus co-infected patients: adequate but not perfect Elise Joëlle Smolders Received Received
  THU-271 Improvement of glycemic state among responders to sofosbuvir – based DAAs Shereen Abdel Alem Received Received
  SAT-271 On-treatment HCV RNA monitoring is not a cost-effective means of identifying non-adherence and has no predictive value Shirin Demma Received Received
  SAT-276 Effect of eradicating hepatitis c on alanine aminotransferase levels Stefan Mauss Received Received
  SAT-277 Worsening of serum lipid profile after direct acting antiviral treatment Stefano Gitto Received Received
  THU-279 Comorbidities and metabolic disorders associated to hepatitis C virus infection: their implications in the severity of the disease and overall mortality risk Fátima Serejo Received Received
  THU-281 Low rate of drug-drug interaction management during interferon-free simeprevir therapy - An integrated analysis of interventional and observational clinical studies Fiona Marra Received Received
  SAT-290 Liver decompensation predicts ribavirin overexposure in HCV cirrhotic patients treated with direct-acting antiviral agents Viola Guardigni Received Received
  SAT-293 Treatment with sofosbuvir and ledipasvir without ribavirin for 12 weeks is highly effective for recurrent hepatitis C after living donor liver transplantation: a Japanese multicenter experience Yoshihide Ueda Received Received
  SAT-298 HEV as a cause of acute hepatitis acquired in Switzerland Montserrat Fraga Christinet Received Received
  FRI-300 Disease spectrum of alcoholic liver disease in beijing 302 hospital from 2002-2013: a large tertiary referral hospital experience from 7422 patients Ang Huang Received Received
  SAT-301 Prevalence of combined PNPLA3 and GCKR variant genotype is increased in patients with risk factors for alcoholic or non-alcoholic liver disease who have clinically significant serum pro-collagen III levels Prarthana Thiagarajan Received Received
  SAT-309 Obesity and steatosis severity affect diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease Yong Jin Jung Received Received
  FRI-311 The effect of nurse performed telemedical video consultations for patients suffering from alcohol-related liver cirrhosis Ghita Bellis Thygesen Received Received
  FRI-314 Physiologic Staging in alcoholic Liver Disease Predicts Death and Monitors Recovery John Carl Hoefs Received Received
  SAT-315 Further delineation of fibrosis progression in NAFLD: evidence from a large cohort of patients with sequential biopsies Stuart Mcpherson Received Received
  SAT-317 Association of A313G polymorphism of GSTP1 gene with certain biochemical markers of liver injury, pro- and anti-inflammatory cytokines in patients with nonalcoholic fatty liver disease Vasyl Prysyazhnyuk Received Received
  SAT-319 Non-alcoholic fatty liver disease – demographic features, risk factors and treatment practices across the Asia Pacific region – the GO ASIA initiative Wah Kheong Chan Received Received
  THU-321 TRAF1 as a marker of exhaustion during chronic hepatitis C Elia Moreno Received Received
  FRI-321 Steatohepatitis: differential features on quantitative liver-spleen scan John Carl Hoefs Received Received
  THU-328 Evaluation of potential futility in alcoholic hepatitis – multicentre study Rita Barosa Received Received
  FRI-331 Effects of gene variants controlling vitamin D metabolism and serum levels on hepatic steatosis Malgorzata Jamka Received Received
  THU-335 Investigating immunomodulatory roles of CX3CR1 related with differentiation and functional polarization of kupffer cells Young-Sun Lee Received Received
  SAT-336 Clinical course and outcome of pregnancy in women with non alcoholic fatty liver disease Nasser Mousa Received Received
  THU-338 Trends in hospital charges and encounters for patients with nonalcoholic fatty liver disease compared to patients with alcohol related liver disease in the United States between 2005 and 2013 Alexander Le Nguyen Received Received
  THU-340 Use of non-invasive methods to assess hepatic steatosis and advanced fibrosis in type-1 diabetic patients Amandeep Singh Received Received
  THU-341 Prevalence of non–alcoholic fatty liver disease and advanced fibrosis in type - 2 diabetic patients via non-invasive methods Naim Alkhouri Received Received
  FRI-341 An open-label randomized clinical study to compare the effects of a nutritional supplement versus vitamin E on fibroscan score in nonalcoholic steatohepatitis patients Mohammad Shahed Ashraf Received Received
  FRI-345 Influence of non-alcoholic fatty liver diease on the course of stable coronary heart disease Iryna Igorivna Vakalyuk Received Received
  THU-347 A new French paradox: morbidly obese patients with NASH have less bulimia than those without NASH Clemence M Canivet Received Received
  SAT-348 The severity of portal inflammation is associated with hepatic fibrosis stage and components of metabolic syndrome in NAFLD Sae Kyung Joo Received Received
  SAT-353 Genetic polymorphism of PTPRD (rs35929428) and risk of non-alcoholic fatty liver disease in Japanese Shunsuke Nakajima Received Received
  THU-355 The role of dysbiosis in the development of non-alcoholic fatty liver disease in obese patients Esther Nistal Received Received
  THU-357 Low vitamin D level is not associated with severity of non-alcoholic fatty liver disease in morbidly obese patients Ana de Lourdes Candolo Martinelli Received Received
  FRI-357 Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mouse Joost Willebrords Received Received
  THU-358 Fasting serum bile acids profile and insulin resistance in healthy blood donors Francesco Azzaroli Received Received
  SAT-359 CD103+ DCs are a key population in the progression of non-alcoholic steatohepatitis: could DCs represent a novel therapeutic application in NASH? Veronika Lukacs-Kornek Received Received
  SAT-365 Exosome derived from palmitic acid-treated hepatocytes activates hepatic stellate cells Young-Sun Lee Received Received
  SAT-369 Prognostic factors for transplant-free survival and external validation of prognostic models in Chinese patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy Ka Shing Cheung Received Received
  FRI-371 Evaluation of spleen length progression rate as a surrogate marker of clinical outcome in patients with primary sclerosing cholangitis Franziska Jung Received Received
  FRI-372 Dysbiosis of the gut microbiota and increased gut permeability characterize secondary sclerosing cholangitis in critically ill patients (SSC-CIP) Andreas Blesl Received Received
  SAT-377 Dynamic risk prediction in Primary Biliary Cholangitis using the UK-PBC cohort Marco Carbone Received Received
  THU-379 Kupffer cell populations share inflammatory tasks and outline a shift in liver resident macrophage population during liver inflammation Christina Mehrfeld Received Received
  THU-386 Protective effect of quercetin treatment on HFD-induced intestinal dysbiosis and barrier dysfunction in an in vivo model of non-alcoholic fatty liver disease Francisco Jorquera Received Received
  THU-393 Liver iron concentration in patients referred for hyperferritinemia: multicenter analysis of the different groups according to HFE mutations and transferrin saturation index, prediction of liver iron overload in Southern Europe Leire Zubiaurre Received Received
  THU-394 Genotypic-phenotypic profile of Wilson disease patients in Lebanon: Comparison with regional Arab countries Aline Kamil El haddad Received Received
  SAT-395 The gut microbiota in liver transplanted primary sclerosing cholangitis patients is characterized by exacerbated dysbiosis Johannes R. Hov Received Received
  SAT-396 miRNA-21-deficiency reduces liver injury, fibrosis and necroptosis in cholestatic bile duct-ligated mice Marta Bento Afonso Received Received
  FRI-403 Circulating fibroblast growth factor 19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis Jian Luo Received Received
  SAT-408 Upregulation of MATE-1 transporter by obeticholic acid correlates with increased biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury Laura Giuseppina Di Pasqua Received Received
  THU-417 Antibiotics induce remission in pediatric PSC-AIH overlap syndrome allowing corticosteroid-free therapy Pauline Sambon Received Received
  SAT-423 Hepatitis B virus infected cell slows down its cell cycle and proliferation by viral protein and replication Kenichi Morikawa Received Received
  THU-423 Prognostic value and prediction of extra-tumoral microvascular invasion among patients who candidate for hepatectomy or liver transplantation for hepatocellular carcinoma Hidetoshi Nitta Received Received
  SAT-425 SLU7 is a survival factor for cancer cells working as a mitotic regulator Maddalen Jimenez Received Received
  THU-430 Progression of familial amyloidosis after domino liver transplantation in donor and recipient Johanna Vollmar Received Received
  THU-434 Effect of diabetes and obesity on short-term outcome after major liver resection Katrin Hoffmann Received Received
  THU-436 A pospective study to evaluate the impact of early everolimus on the recurrence of hepatocellular carcinoma after liver transplantation Manuel Rodríguez-Perálvarez Received Received
  FRI-438 Characterisation of the immune response in patients with drug induced liver injury Giacomo Germani Received Received
  FRI-449 Drug-induced liver injury: presentations, causes and outcomes: an Egyptian study Omkolthoum Alhadad Received Received
  THU-451 History of marijuana use does not affect outcomes on the liver transplant waitlist Prashant Kotwani Received Received
  SAT-451 Inhibition of canonical WNT signaling pathway by ß-catenin/CBP inhibitor ICG001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12 Ruchi Bansal Received Received
  THU-456 MELD score > 19 on day five after liver transplant in hepatitis C virus-positive recipients: impact on 90-day graft loss and analysis of predictors Silvia Martini Received Received
  SAT-460 Morphology based assessment of liver fibrosis using a new quantitative metric in abdominal CT scans Andreas Christe Received Received
  THU-462 The burden of healthcare utilization after liver transplantation and its relationship with pre-transplant hospitalization Therese Bittermann Received Received
  FRI-465 Do elevated liver values necessarily indicate a health problem or could poorly defined upper limits of normal be an issue? Alanine aminotransferase and gamma-glutamyltransferase depend strongly on age Johannes Wiegand Received Received
  SAT-465 Acoustic Radiation Force Imaging the Fontan liver – feasibility and reproducibility Amanda J Nicoll Received Received
  FRI-468 Smoking and metabolic syndrome components are independent predictors of mortality in patients with chronic liver disease in the United States Karn Wijarnpreecha Received Received
  SAT-469 ECV-associated miRNA levels as non-invasive biomarkers for early-stage HBV/HCV-induced liver fibrosis Joeri Lambrecht Received Received
  FRI-470 Inadequate identification of fatty liver disease, obesity, and metabolic syndrome by family physicians Mahmud Mahamid Received Received
  SAT-470 Non-invasive fibrosis markers are independent predictors of mortality among U.S. adults with nonalcoholic fatty liver disease Karn Wijarnpreecha Received Received
  SAT-471 Association between non-invasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease in the United States Karn Wijarnpreecha Received Received
  FRI-473 Non-steroid anti-inflammatory drugs for biliary colic Mirella Fraquelli Received Received
  THU-473 Human leukocyte antigen matching in living donor liver transplantation: does it affects the outcome? Iman Montasser Received Received
  THU-475 The non-alcoholic fatty liver disease liver fat score is associated with liver disease mortality in the United States population Aynur Unalp-Arida Received Received
  SAT-477 Effect of meal ingestion on liver stiffness and controlled attenuation parameter Marco Silva Received Received
  SAT-480 Circulating Fibroblast Activation Protein activity as a liver fibrosis biomarker in NAFLD Geoffrey William McCaughan Received Received
  SAT-492 The assessment of liver fibrosis stage by two-dimensional shear wave ultrasound and transient elastography in patients with chronic liver disease Sang Gyune Kim Received Received
  THU-495 Predictive value of S-GGT for severe liver disease in the general population – a population-based cohort study with over a decade of follow-up Fredrik Åberg Received Received
  SAT-499 Impact of hepatic steatosis and controlled attenuation parameter (CAP) on accuracy of fibrosis staging using transient elastography Thomas Karlas Received Received
  SAT-500 The effect of liver steatosis on non-invasive measurement of liver iron concentration by spin-density projection assisted R2-MRI (FerriScan) Tim Guy St Pierre Received Received
  SAT-502 Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein as a serum biomarker for disease severity in non-alcoholic fatty liver disease Wah Kheong Chan Received Received
  THU-503 Serum immunoglobulin levels are related to histological severity of primary biliary cholangitis Huan Wang Received Received
  FRI-503 Laparoscopic liver resection for hepatocellular carcinoma located in segments 7 or 8 Hanisah Guro Received Received
  LBP-532 Potential viral triggers for pediatric and adult autoimmune hepatitis Richard Taubert Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon - Fri 8:15 - 15:00
14:39
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image
 

EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

The International Liver Congress 2017

 

19-23 April 2017 Amsterdam
HELP LINE
Manage Orders
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 18/04/2017 TO 18/04/2017
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                   DOI: 10.3252/pso.eu.ILC2017.2017 
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 20/03/2017
Upload Poster
Upload Oral Presentation of Video
Upload
Poster
Upload Oral
Presentation or Video





PosterSessionOnline
Logo Draft
 
Logo Cert